Orasis is an emerging ophthalmic pharmaceutical company with the goal of making near vision clear again. They are committed to the Ophthalmology and Optometry segments because they know that presbyopia is ubiquitous. By virtue of their first in class formulation, Orasis is well-positioned to be first-line therapy in this emerging category by addressing a significant unmet need for patients.

Pharmaceutical

Orasis Pharmaceuticals

Elad Kedar

Yaron Shimon

Merav Zeide

Ilan Rubin

Paul Smith

Iris Meisner

Ron Neumann

Sharon Amzel-Sasson

The executive team at Orasis Pharmaceuticals has a history in general management, marketing, finance, technology sales, and ocular drug development. They have experience working for companies such as Mediline LTD, PharmaSwiss, Eli Lilly, Novartis, TearLab Corporation, Alcon, BIOLIGHT Life Sciences Ltd., Tarsier Pharma, and Teva Pharmaceuticals. They have received education from universities such as Tel Aviv University, University of Florida - Warrington College of Business, University of Central Florida, and Mass Eye and Ear Infirmary at Harvard University.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Orasis Pharmaceuticals

Board of Directors

Leadership Team